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Trace amines, including tyramine and b-phenylethylamine (b-PEA), are constituents of many foods including chocolate, cheeses and wines and
are generated by so-called ‘friendly’ bacteria such as Lactobacillus, Lactococcus and Enterococcus species, which are found in probiotics. We
therefore examined whether these dietary amines could exert pharmacological effects on the gut and its vasculature. In the present study we exam-
ined the effects of tyramine and b-PEA on the contractile activity of guinea-pig and rat ileum and upon the isolated mesenteric vasculature and
other blood vessels. Traditionally, these amines are regarded as sympathomimetic amines, exerting effects through the release of noradrenaline
from sympathetic nerve endings, which should relax the gut. A secondary aim was therefore to confirm this mechanism of action. However, con-
tractile effects were observed in the gut and these were independent of noradrenaline, acetylcholine, histamine and serotonin receptors. They were
therefore probably due to the recently described trace amine-associated receptors. These amines relaxed the mesenteric vasculature. In contrast,
the aorta and coronary arteries were constricted, a response that was also independent of a sympathomimetic action. From these results, we propose
that after ingestion, trace amines could stimulate the gut and improve intestinal blood flow. Restriction of blood flow elsewhere diverts blood to the
gut to aid digestion. Thus, trace amines in the diet may promote the digestive process through stimulation of the gut and improved gastrointestinal
circulation.
Dietary trace amines: Gut contractile activity: Vascular activity: Mesenteric bed
Trace amines, including tyramine and b-phenylethylamine
(b-PEA), are biologically active amines occurring in the
body in trace amounts. They are also found in the diet, derived
from plants, bacteria and fungi(1). Foods rich in tyramine and
b-PEA include cheeses, red wine, fermented foods, such as sau-
sages, and cocoa-containing foods, such as chocolate(2). The
recently popularised probiotic foods owe their reputed ben-
eficial effects on health to high levels of lactic acid-producing
bacteria such as Lactobacillus, Lactococcus and Enterococcus
species. These are said to be ‘friendly’ bacteria, displacing
harmful bacteria of the gut flora(3) and combating infectious
diarrhoea(4). Their commercial promotion is also based on a
perceived ability to alleviate bloating and abdominal disten-
sion(5). Indeed, there is clinical evidence that bloating(6) and
flatulence(7,8) associated with irritable bowel syndrome are
reduced by probiotic bacterial supplements. It is not generally
recognised, however, that the bacterial populations present in
probiotic foods generate considerable levels of tyramine and
b-PEA(9).
Since trace amines are abundant in many foods and in
drinks taken before or after meals (aperitifs, chocolates)(2),
in the present study we determined their effects on the gut
and its vasculature. We examined the pharmacological effects
of tyramine and b-PEA in isolated sections of gut from the
guinea-pig or rat ileum which were electrically stimulated to
simulate peristalsis. We also examined their effects on the
mesenteric vasculature as an index of effects on blood flow
to the gut, using rat isolated perfused mesenteric beds and
compared these with the aorta and coronary vasculature.
Trace amines, such as tyramine and b-PEA, are classically
regarded as having indirect sympathomimetic activity(10). How-
ever, our recent studies have demonstrated a vasoconstriction
by related amines that is independent of indirect sympathomi-
metic activity(11 – 13). This raises the possibility that trace
amines can also exert physiological effects through other recep-
tors, such as the recently cloned trace amine-associated (TAA)
receptors (14 – 17). Thus, a secondary aim of the present study was
to examine whether the effects of tyramine and b-PEA on
the gut and its vasculature were mediated through sympatho-
mimetic-dependent or -independent mechanisms.
Experimental methods
Isolated ileum
Male Sprague–Dawley rats (250–300 g; Harlan, Bicester,
Oxon, UK) or Dunkin–Hartley guinea-pigs (250–400 g;
Harlan) were killed by cervical dislocation and exsanguination.
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The guidelines for the care and use of laboratory animals were
followed according to the Animals (Scientific Procedures) Act
1986.
Sections (2 cm) of ileum were isolated from rats or guinea-
pigs and set up in tissue baths containing Krebs bicarbonate
buffer (pH 7·4) at 378C gassed with 5 % CO2 in O2. The
Krebs bicarbonate buffer was made up in distilled water and
had the following composition (mM): NaCl, 100; NaHCO3,
20; glucose, 10; MgSO4·7H2O, 1; KH2PO4, 1; KCl, 5;
CaCl2·2H2O, 3. To simulate peristalsis, tissues were electri-
cally stimulated with square-wave pulses (0·1 Hz, 5 ms pulse
width, 10 V) via parallel platinum electrodes located inside
and outside the lumen. Isometric tension was measured by
force transducers (Dynamometer UF1, 57 g sensitivity range;
Pioden Controls Ltd, Canterbury, Kent, UK) coupled to a
PowerLab/4SP computerised data acquisition system (ADIn-
struments, Charlgrove, Oxon, UK). Data were analysed
using Chart version 4.1.1 software (ADInstruments). b-PEA
or tyramine was added cumulatively in half-logarithmic incre-
ments in molar concentration to the tissue baths until the
maximum effect was achieved.
Mesenteric bed
Male Sprague–Dawley rats (250–300 g) were killed by cervi-
cal dislocation and exsanguination. The superior mesenteric
artery was cannulated and the mesenteric arterial bed excised
and placed in a perfusion chamber. The bed was perfused at a
constant flow rate (4 ml/min) with Krebs bicarbonate solution,
warmed to 378C and gassed with 95 % O2–5 % CO2.
Perfusion pressure was monitored by means of a pressure
transducer (Elcomatic EM 750; Elcomatic Ltd, Glasgow,
UK) connected to a computer data acquisition system (ADIn-
struments PowerLab, Chart 5). Increasing bolus doses (100ml)
of b-PEA or tryramine were injected, each dose added after
recovery of the response to the previous dose.
Aortic ring preparations
Rings (3 mm) were cut from the thoracic or abdominal aorta of
male Sprague–Dawley rats (250–300 g) or Dunkin–Hartley
guinea-pigs (250–400 g) and passed over fixed and mobile
hooks. The latter was connected to an isometric transducer
(Dynamometer UF1, 57 g sensitivity range; Pioden Controls
Ltd, Canterbury, Kent, UK), a resting tension of 1·5 g applied
and tension recorded on a computerised data acquisition
system (ADInstruments PowerLab, Chart 5). Tissues were
bathed in Krebs bicarbonate buffer (378C) gassed with 95 %
O2–5 % CO2. Endothelium was removed by rolling the ring
around a wooden cocktail stick. Endothelium denuding was
confirmed by failure of acetylcholine (100mM) to relax
aortae pre-contracted with the selective thromboxane A2 ago-
nist, U46619 (9,11-dideoxy-9a, 11a-epoxymethanoprosta-
glandin F2a;1mM). After 1 h equilibration, isotonic KCl
(60 mM) was added to contract the tissue to test for tissue via-
bility and as a standardisation response. After washout, non-
cumulative concentration–response curves (CRC) for b-PEA
or tyramine were constructed by adding successive concen-
trations in half-logarithmic increments with washout between
each. CRC were obtained either in the absence or presence of
the inhibitors, prazosin (1mM), ICI-118,551 (1mM), cocaine
(10mM) and pargyline (10mM), which were incubated with
the tissue for 15 min before commencing the CRC.
Pig coronary artery rings
Left anterior descending coronary arteries were dissected from
porcine (either sex) hearts after transport at 48C from the abat-
toir. Rings (5 mm long) were mounted in tissue baths and iso-
metric tension recorded as described for aortic rings. Tissue
viability was initially determined by contracting with
60 mM-KCl. After washout, intact endothelium was confirmed
by at least 70 % relaxation to10mM-bradykinin in rings pre-
contracted with U46619 (5 nM). Acetylcholine contracts
rather than relaxes pig coronary arteries(13,18) and is therefore
unsuitable for testing for the presence of endothelium
and endothelium-derived relaxation. Baseline tensions were
re-established by washing before obtaining a cumulative
CRC to tyramine or b-PEA.
Measurement of responses and analysis of results
In isolated ileum preparations, increases in the baseline con-
tractions to b-PEA or tyramine were plotted as a percentage
of the maximum response to methacholine (acetyl-b-methyl-
choline) added at the start of the experiment or as a percentage
of the maximum contractile response.
Responses of the mesenteric vascular bed were measured as
the peak fall in perfusion pressure after each dose of tyramine
or b-PEA and plotted as a percentage of the constriction by
phenylephrine. Constrictions of aortic and coronary artery ring
preparations above baseline were measured at the peak response
to each concentration of b-PEA or tyramine and expressed as a
percentage of the contraction to KCl (60 mM) added at the begin-
ning of an experiment. CRC for the mean responses with their
standard errors were plotted against log molar concentration.
Geometric mean EC50 values (molar concentration for 50 %
of maximal response) and their 95 % CI were calculated. To
enable comparisons with a standard contractile agent in the
ileum, responses were also expressed as a percentage of the
maximum response to methacholine; because the maximum
did not always reach 50 % of the methacholine maximum,
the EC30 values (molar concentration for 30 % of the maxi-
mum response to methacholine) were calculated. EC30 and
EC50 values and maximum responses expressed as a
percentage of methacholine (ileum) or KCl contractions
(aorta and coronary artery) were compared by Student’s t
test for paired or unpaired two-set data or by ANOVA
followed by post hoc Bonferroni’s tests for multiple compari-
sons. P,0·05 was deemed significant.
Materials
The following drugs were used: acetylcholine chloride, atropine sul-
fate, bradykinin triacetate, cocaine hydrochloride, 5-hydroxy
tryptamine (5-HT) hydrochloride (serotonin), methacholine (acetyl-
b-methylcholine) chloride, pargyline hydrochloride, (R)-(2)-
phenylephrine hydrochloride, 2-phenylethylamine hydrochloride
(b-phenylethylamine), (^)-propranolol hydrochloride, prazosin
hydrochloride, ritanserin, tyramine hydrochloride (p-tyramine),
U46619 (9,11-dideoxy-9a, 11a-epoxymethanoprostaglandin F2aa)
(Sigma-Aldrich, Poole, Dorset, UK), ICI-118,551 hydrochloride
K. J. Broadley et al.1646
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((^)-1-(2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy(-3-((1-methylet-
hyl) amino(-2-butanol hydrochloride) (Tocris Bioscience, Bristol,
UK) and phentolamine mesylate (Rogitinew; Alliance Pharmaceuti-
cals, Chippenham, Wilts, UK).
All chemicals for the Krebs bicarbonate buffer were of
analytical grade and were obtained from Fisher Scientific
(Loughborough, Leics, UK) unless otherwise stated. All
drugs were dissolved in distilled water, except for prazosin,
ICI-118,551 and U46619, which were dissolved in dimethyl
sulfoxide and ritanserin which was dissolved in alcohol.
Neither dimethyl sulfoxide nor alcohol at the concentrations
employed exerted significant effects on coronary artery or
ileum responses, respectively.
Results
Ileum
Both guinea-pig and rat electrically stimulated ileum exhibited
concentration-related contractions in response to tyramine and
b-PEA (Fig. 1). Tissue sections also contracted to tyramine
and b-PEA without electrical stimulation. In guinea-pig unsti-
mulated ileum, the geometric mean EC30 values for tyramine
and b-PEA were 1·89 (95 % CI 0·88, 4·06) £ 1024 and 6·54
(95 % CI 3·68, 11·6) £ 1024 M, respectively, yielding a
potency ratio of 0·3. The maximum responses as a percentage
of methacholine maximum contraction were 73·0 (SEM 2·0)
and 53·9 (SEM 5·9) %, respectively. In unstimulated guinea-
pig ileum, the corresponding maxima were 78·0 (SEM 2·0)
and 58·6 (SEM 1·7) %, respectively. In guinea-pig electrically
stimulated ileum, the non-selective a- and b-adrenoceptor
antagonists phentolamine (1026 M) and propranolol (1026
M) failed to block the contractions to tyramine (Fig. 2 (a))
or b-PEA (Fig. 2 (b)). The geometric mean EC50 values for
tyramine in unstimulated preparations in the absence (2·56
(95 % CI 1·24, 5·20) £ 1024 M or presence of both antagonists
(3·48 (95 % CI 2·88, 4·21) £ 1024 M) were not significantly
different. Similarly, the EC50 values for b-PEA in the absence
(2·51 (95 % CI 1·50, 4·20) £ 1024 M) or presence of phentola-
mine (2·51 (95 % CI 1·87, 3·37) £ 1024 M), propranolol (2·51
(95 % CI 2·02, 3·13) £ 1024 M) and both antagonists (2·51
(95 % CI 1·87, 3·37) £ 1024 M) did not differ significantly.
The increase in baseline tension of guinea-pig electrically
stimulated ileum by b-PEA was not blocked by the non-selec-
tive muscarinic acetylcholine receptor antagonist, atropine
(1026 M), whereas contractions to electrical stimulation were
abolished. The EC50 values for b-PEA in the absence (5·32
(95 % CI 1·8, 15·3) £ 1024 M) or presence of atropine (3·16
(95 % CI 2·04, 4·91) £ 1024 M; n 4) did not differ signi-
ficantly. The 5-HT2A/B/C receptor antagonist, ritanserin
Fig. 1. Typical traces of the contractile effects of b-phenylethylamine
(b-PEA) on electrically stimulated guinea-pig (a) and rat (b) isolated intestine.
Both show b-PEA increasing the baseline tension.
Fig. 2. Concentration–response curves for increases in baseline contractions
of guinea-pig electrically stimulated ileum to (a) tyramine and (b) b-pheny-
lethylamine (b-PEA). (a) Tyramine responses plotted as percentages of the
maximum response to methacholine (acetyl-b-methylcholine) in the absence
(O; n 7) and presence of phentolamine (1026 M) and propranolol (1026 M; B;
n 4). (b) b-PEA responses plotted as percentages of the maximum response,
in the absence (B) and presence of phentolamine (1026 M; O), propranolol
(1026 M; ) or phentolamine and propranolol (S). Values are means, with
standard errors represented by vertical bars.
Dietary trace amines in the gut 1647
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(1026 M)(19), abolished 5-HT contractions (Fig. 3 (a)) but
did not shift the CRC for the contraction of guinea-pig
ileum to b-PEA (Fig. 3 (b)). The EC50 values in the absence
(3·16 (95 % CI 1·52, 6·58) £ 1024 M) or presence of ritanserin
(5·01 (95 % CI 1·16, 21·7) £ 1024 M) were not significantly
different.
Mesenteric vascular bed
The responses of the vascular bed of the gastrointestinal
tract to increasing bolus doses of tyramine and b-PEA
were measured in rat isolated perfused mesenteric beds.
Resting perfusion pressure was little affected by tyramine
and b-PEA. However, when perfusion pressure was raised
by infusion of the a-adrenoceptor agonist, phenylephrine
(100mM), tyramine and b-PEA caused dose-related falls in
perfusion pressure indicative of vasodilatation (Fig. 4). The
maximum pressure falls were to 84·2 (SEM 4·3) and 59·9
(SEM 5·4) % of the phenylephrine-induced rise in pressure,
respectively.
Aortic rings
Tyramine and b-PEA were next examined in guinea-pig and
rat isolated aortic ring preparations, from which the endo-
thelium was removed. In contrast to the mesenteric vascula-
ture, b-PEA and tyramine produced concentration-related
vasoconstriction. These responses persisted in the presence
of prazosin (1mM), ICI-118,551 (1mM), cocaine (10mM) and
pargyline (10mM) to block a1- and b2-adrenoceptors, uptake
of sympathomimetic amines and monoamine oxidases A and
B, respectively (Fig. 5). The maximum vasoconstriction to tyr-
amine (62·5 (SEM 23·9) % of KCl contraction) was signifi-
cantly less than to b-PEA (138·3 (SEM 23·9) %) in rat aorta.
Tyramine could therefore be regarded as a partial agonist.
Pig coronary artery
To examine a smaller vessel rather than a major conductance
vessel such as the aorta, we used isolated rings of pig left
anterior descending coronary arteries with intact endothelium.
Cumulative CRC to tyramine or b-PEA were obtained. Tyra-
mine and b-PEA caused concentration-dependent vasocon-
striction (Fig. 6) which reached maxima of 51·0 (SEM 6·6)
(n 4) and 74·3 (SEM 9·1) %, respectively, of the KCl constric-
tion. These constrictions were not prevented by the a1-adreno-
ceptor antagonist, prazosin (1mM) (Fig. 6).
Fig. 3. (a) Baseline contractions of guinea-pig electrically stimulated ileum to
5-hydroxytryptamine (5-HT; 3 £ 1026 M), plotted as percentages of the maxi-
mum response to methacholine (acetyl-b-methylcholine), before (A) and in
the presence of ritanserin (B; 1026 M). Values are means, with standard
errors represented by vertical bars. * Mean value was significantly different
from that pre-ritanserin (P,0·05). (b) Concentration–response curves for
increases in baseline contraction of guinea-pig electrically stimulated ileum to
b-phenylethylamine, plotted as percentages of the maximum response to
methacholine, in the absence (B) and presence of ritanserin (1026 M; O).
Values are means (n 4), with standard errors represented by vertical bars.
Fig. 4. Vasodilator effects of b-phenylethylamine (b-PEA) and tyramine in rat
isolated perfused mesenteric vascular beds. (a) Typical trace for falls in per-
fusion pressure of the mesenteric bed with increasing doses of b-PEA with
resting perfusion pressure raised by infusion of phenylephrine (Phe, 100mM).
The initial spike increases in pressure are injection artifacts. (b) Dose–
response curves for falls in mesenteric vascular pressure to tyramine (O; n 4)
and b-PEA (A n 4), plotted as percentages of the increase in pressure by
Phe against concentration (mg/100ml). Values are means, with standard
errors represented by vertical bars.
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Discussion
Tyramine and b-PEA contracted both guinea-pig and rat iso-
lated gut preparations. In the guinea-pig ileum, tyramine con-
sistently produced a greater maximum response (relative to
the methacholine maximum contraction) than b-PEA, whether
in electrically stimulated or unstimulated tissues. These
responses were not inhibited by antagonists of the major neu-
rotransmitters of the gut, namely noradrenaline, acetylcholine
and 5-HT via adrenoceptors, muscarinic receptors and 5-HT2
receptors, respectively. A contractile response of the gut is
opposite to that expected of sympathomimetic amines, such
as noradrenaline and adrenaline, which relax the gastrointesti-
nal tract(20,21). The relaxation is due to direct activation of
b1- and a1-adrenoceptors on the longitudinal smooth
muscle(22). Indirect sympathomimetic amines such as tyramine
have also been shown to reduce myogenic activity of rabbit
ileum, an effect attributed to the release of noradrenaline
from sympathetic neurones in the gastrointestinal wall(23).
However, the more usual response reported in the literature
has been a contraction to tyramine and b-PEA of guinea-pig
ileum(24) and rabbit jejunum(21,25), an effect that unlike the
present findings was attributed to stimulation of 5-HT recep-
tors(24,25). However, in these relatively old studies, the selec-
tivity of available antagonists was poor. Furthermore, it was
found that desensitisation of 5-HT receptors by prolonged
exposure to 5-HT abolished the contractions to 5-HT but not
b-PEA(25), suggesting that b-PEA was not operating through
5-HT receptors.
These results have therefore shown that tyramine and b-PEA
contract rather than relax the gut, a response that is inconsistent
with a sympathomimetic action. Furthermore, the response is not
abolished by antagonists of muscarinic or 5-HT receptors that
are known to mediate contraction of the gut. Similarly, the vaso-
constrictor actions of tyramine and b-PEA in rat and guinea-pig
aortic and pig coronary blood vessels were resistant to adreno-
ceptor blockade. Therefore the vasoconstriction remaining in
the presence of these antagonists was not due to noradrenaline
release from sympathetic neurones in the aortic wall. Therefore
b-PEA and tyramine were not behaving as indirect sympathomi-
metic amines by acting. In contrast to the aorta and coronary
arteries, tyramine and b-PEA failed to constrict the mesenteric
blood vessels supplying the gastrointestinal tract. Instead,
when the pressure was raised by infusing phenylephrine, there
was vasodilatation.
The present results overturn the dogma that has persisted for
over 30 years that these amines owe their pharmacological
actions to indirect sympathomimetic properties. They can
clearly exert contractile effects on the gut and blood vessels
via an alternative and hitherto unidentified pathway. Trace
amines have been shown to bind to receptors now called
TAA receptors(16,17,26). These receptors were identified by the
selection of oligonucleotide sequences based on G-protein-
coupled receptors for serotonin(14) or dopamine(15) and ampli-
fication by PCR of novel DNA sequences. Cell lines were then
transfected with the cloned sequences resulting in novel
orphan receptors coupled to cAMP production. Several TAA
receptors have now been cloned but only TAA receptors 1
and 4 are contenders for a functional role since only these
recognise tyramine or b-PEA(16,26). We therefore propose
that tyramine and b-PEA exert their non-adrenergic responses
via trace amine receptors. Human embryonic kidney
(HEK293) cells stably expressing rat TAA 1 receptors show
tyramine to be more potent than b-PEA for cAMP accumu-
lation by potency ratios of 0·23(17) or 0·29(15). The TAA recep-
tor 4 receptor expressed in COS-7 cells shows stimulation of
cAMP for which b-PEA is 8·9-fold(26) more potent than tyra-
mine. In the present studies, the potency ratios were 0·62
(EC50 ratio) in pig coronary artery, 0·13 (EC50 ratio in the pre-
sence of antagonists) in guinea-pig aorta and 0·30 (EC30 ratio
in the presence of propranolol and phentolamine) in the unsti-
mulated guinea-pig ileum. Tyramine was therefore marginally
Fig. 5. Vasoconstrictor effects of b-phenylethylamine (b-PEA) and tyramine
in rat and guinea-pig isolated aortic rings. (a) Concentration–response
curves (CRC) for constriction of guinea-pig aortic rings by b-PEA in the
absence (A) and presence of the inhibitors prazosin (1mM), ICI-118,551
(1mM), cocaine (10mM) and pargyline (10mM) ( ). Values are means (n 6),
with standard errors represented by vertical bars. (b) CRC for the constriction
of guinea-pig aortic rings by tyramine in the absence (A) and presence of the
inhibitors ( ). Values are means (n 5), with standard errors represented
by vertical bars. (c) CRC for the constriction of rat aortic rings by tyramine
(A n 4) and b-PEA ( ; n 6) in the presence of the inhibitors. Values are
means, with standard errors represented by vertical bars.
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more potent than b-PEA, suggesting a role for TAA receptor 1.
However, in the rat aorta tyramine was a weak partial agonist,
which, assuming that it interacts with the same receptor as
b-PEA, does not support the contention of TAA receptor 1
involvement. Furthermore, the contractile responses observed
here are clearly not due to cAMP generation which would
relax smooth muscle(20). Further work is necessary to charac-
terise the receptors involved in these native tissues and a
major breakthrough would be the identification of a selective
antagonist which is currently unavailable.
Concentrations of tyramine and b-PEA in the circulation
comparable with those revealing effects on the gut and vascu-
lature could be achieved by a number of means. Pressor
responses are typically associated with a high dietary intake
of tyramine, especially in individuals taking monoamine oxi-
dase inhibitors to prevent its degradation in the intestine
before reaching the circulation(26), in smokers who have
lower monoamine oxidase A and B levels(27) and in women
taking isoflavones as an alternative to hormone replacement
therapy(28). Plasma levels of tyramine are also elevated in
hypertensive patients(29) and in patients with migraine head-
aches(30). Pressor responses are induced by the oral adminis-
tration of doses of tyramine in the range 100–200 mg and
the oral dose of tyramine to produce a 30 mmHg rise in systo-
lic blood pressure is approximately 7 mg/kg (500 mg in a 70 kg
subject)(31). Tyramine concentrations able to induce pressor
responses can reach these levels in many fermented foods
such as sausages (. 200 mg/kg)(32) and goat (2000 mg/kg)(33)
and Dutch cheese (300 mg/kg)(34). The concentrations of
tyramine in the gut will be higher than in the circulation and in
the range capable of stimulating the gut found in the present study.
From the present results we can hypothesise that trace
amines, such as tyramine and b-PEA, found in the diet may
have a physiological role in mammalian digestion. After
ingestion, they stimulate the gut thereby facilitating digestion.
The concomitant vasodilatation of the mesenteric vascular
bed and increased blood flow to the gastrointestinal tract
would provide energy to support the enhanced gut
motility and release of digestive enzymes, and assist transport
of absorbed nutrients from the gut(35). Increases in visceral
blood supply are met by a compensatory restriction of blood
supply to some other organs(35). The vasoconstrictor effects
of tyramine and b-PEA on blood vessels other than those of
the mesentery are demonstrated by the vasoconstriction
observed here in the aorta and coronary arteries. Thus, the
relief of bloating(6) and increased transit through the gut(36)
Fig. 6. Vasoconstrictor effects of b-phenylethylamine (b-PEA) and tyramine in isolated rings from pig left anterior descending coronary artery. (a) Typical trace
for a concentration–response curve (CRC) for the constrictor response to b-PEA. (b) Typical trace for a CRC for the constrictor response to b-PEA in the
presence of prazosin (1mM). (c) CRC for tyramine in the absence (B) and presence of prazosin (A; 1mM). Values are means (n 4), with standard errors
represented by vertical bars. (d) CRC for b-PEA in the absence (O) and presence of prazosin (K; 1mM). Values are means (n 4), with standard errors represented
by vertical bars.
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that has been reported for probiotics could be due to increased
gut activity by the generation of trace amines by their content
of Lactobacillus, Lactococcus and Enterococcus species. Our
hypothesis could also apply to other foods such as cocoa
products, cheeses, sausages and red wine, which are often
eaten before or after meals in the belief that they aid digestion.
Our hypothesis will require verification in vivo to show that
the effects of trace amines seen here in vitro can be extended
to their oral administration, and reproduced after ingestion of
trace amine-rich foods.
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